Diagnostic and Prognostic Value of New Biomarkers in Patients With Heart Disease
NCT ID: NCT01374880
Last Updated: 2013-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2009-06-30
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this work is to investigate and then to sequence new proteins in the plasma of these patients for diagnostic and prognostic purpose.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dyspnea cohort
Dyspnea cohort
No interventions assigned to this group
Stable chronic heart failure
Stable chronic heart failure
No interventions assigned to this group
Valvular heart disease
Valvular heart disease
No interventions assigned to this group
Ventricular assist device
Ventricular assist device
No interventions assigned to this group
Cardiac arrest
Cardiac arrest
No interventions assigned to this group
Cardiac rehabilitation
Cardiac rehabilitation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with valvular disease
* chronic stable heart failure.
* post- partum Cardiomyopathy
Exclusion Criteria
* progressive neurological disease
* pregnancy
* opposition of the patient
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
University Paris 7 - Denis Diderot
OTHER
ThermoFisher Scientific Brahms Biomarkers France
INDUSTRY
Hoffmann-La Roche
INDUSTRY
Alere San Diego
INDUSTRY
Servier
INDUSTRY
Helsinki University Central Hospital
OTHER
University Hospital, Basel, Switzerland
OTHER
Massachusetts General Hospital
OTHER
The Cleveland Clinic
OTHER
Maastricht University Medical Center
OTHER
Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria
UNKNOWN
Hospital Universitario Virgen de la Arrixaca
OTHER
University Hospital Monastir, Tunis
OTHER
Università degli Studi di Brescia
OTHER
Intensive and Cardiac Care Unit, Nippon Medical School, Tokyo, Japan
UNKNOWN
Brno University Hospital
OTHER
University of Cape Town
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alain Cohen-Solal, PHD
Role: STUDY_DIRECTOR
Institut National de la Santé Et de la Recherche Médicale, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lariboisiere hospital
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Said Laribi, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Badoz M, Arrigo M, Mogenet AC, Sadoune M, Meneveau N, Mebazaa A, Seronde MF. Assessment of successful percutaneous mitral commissurotomy by MRproANP and sCD146. BMC Cardiovasc Disord. 2020 Apr 5;20(1):157. doi: 10.1186/s12872-020-01435-y.
Van Aelst LNL, Abraham M, Sadoune M, Lefebvre T, Manivet P, Logeart D, Launay JM, Karim Z, Puy H, Cohen-Solal A. Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up. Eur J Heart Fail. 2017 Aug;19(8):1075-1076. doi: 10.1002/ejhf.837. Epub 2017 May 17. No abstract available.
Vodovar N, Seronde MF, Laribi S, Gayat E, Lassus J, Boukef R, Nouira S, Manivet P, Samuel JL, Logeart D, Ishihara S, Cohen Solal A, Januzzi JL Jr, Richards AM, Launay JM, Mebazaa A; GREAT Network. Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure. Eur Heart J. 2014 Dec 21;35(48):3434-41. doi: 10.1093/eurheartj/ehu314. Epub 2014 Aug 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Unité 942 INSERM
Identifier Type: OTHER
Identifier Source: secondary_id
CNIL number: 910198
Identifier Type: -
Identifier Source: org_study_id